Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

I. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Schattenberg, Joern M.; Straub, B. K.

Differential diagnosis of fatty liver disease

GASTROENTEROLOGE. Bd. 15. H. 2. 2020 S. 88-95


Woermann, Bernhard; Bokemeyer, Carsten; Burmeister, Thomas et al.

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. 11. 2020 S. 628-636


Hahn, Felix; Mueller, Lukas; Maehringer-Kunz, Aline et al.

Distant Metastases in Patients with Intrahepatic Cholangiocarcinoma: Does Location Matter? A Retrospective Analysis of 370 Patients

JOURNAL OF ONCOLOGY. Bd. 2020. 2020



Galle, P. R.; Knox, J.; Lencioni, R. et al.

Durvalumab with or without bevacizumab as adjuvant therapy for HCC patients at risk of recurrence after curative therapy: EMERALD-2

ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. SUPPL 4. 2020 S. 123-124


Schwarting, Andreas

Editorial

BEWEGUNGSTHERAPIE UND GESUNDHEITSSPORT. Bd. 36. H. 1. 2020 S. 1-1


Michel, Maurice; Schattenberg, Joern M.

Effectiveness of lifestyle interventions in NAFLD (nonalcoholic fatty liver disease) - how are clinical trials affected?

EXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 29. H. 2. 2020 S. 93-97



Schattenberg, Joern M.

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis

VISCERAL MEDICINE. Bd. 36. H. 5. 2020 S. 411-416


Weusten, Bas L. A. M.; Barret, Maximilien; Bredenoord, Albert J. et al.

Endoscopic management of gastrointestinal motility disorders - part 1: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

ENDOSCOPY. Bd. 52. H. 6. 2020 S. 498-515